the following concentrations: 0.03 mg/ml chloramphenicol (Cm), 0.1 mg/ml carbenicillin (Carb), 0.05 mg/ml kanamycin (Kan), and 0.01 mg/ml tetracycline (Tet).
Bacterial strains. The E. coli strains used in this study are listed in Supplementary Table 1 . The EcN (Mutaflor, DSM 6601) wild-type strain was kindly provided by Ardeypharm GmbH, Herdecke, Germany. All strains were routinely grown aerobically in LB broth (10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl) or on LB agar plates (15 g/l agar) at 37°C. When appropriate, antibiotics were added to the media at the following concentrations: 0.03 mg/ml chloramphenicol (Cm), 0.1 mg/ml carbenicillin (Carb), 0.05 mg/ml kanamycin (Kan), and 0.01 mg/ml tetracycline (Tet).
Construction of plasmids.
Standard molecular cloning techniques were performed as described previously (22) to generate the plasmids listed in Supplementary   Table 1 . The oligonucleotides used to amplify DNA fragments by PCR are listed in Supplementary Table 2 . PCR products were routinely cloned into pCR2.1 using the TOPO TA cloning kit (Life Technologies, Carlsbad) and sequenced prior to subcloning. pKD46 (23) was digested with AccI and ClaI, and the Klenow-treated, 3.2 kb DNA fragment was religated to create pSW172. To construct pSW224, pSW225, pSW237, and pSW248, respectively, DNA regions upstream and downstream of the EcN napA, narG, narZ, and moaA genes were amplified by PCR, digested with XbaI and ligated using T4 DNA ligase. DNA fragments comprising the linked flanking regions of each gene were PCR-amplified from the ligation products, cloned into pRDH10 using either the BamHI (pSW224), SphI (pSW225), EcoRI (pSW237), or SphI/SalI (pSW248) restriction enzyme sites. The moaA gene and the narG gene were PCR-amplified with their native promoter regions from the EcN chromosome and cloned into pWSK29 utilizing the restriction enzymes XhoI/HindIII (pMOA1) and XhoI (pNARG1) to generate pMOA1 and pNARG1, respectively. pSW268 was created by amplifying the EcN napA gene including the upstream and downstream regions and cloning this DNA fragment into pRDH10 via BamHI restriction sites.
Construction of mutants by allelic exchange. Suicide plasmids were routinely propagated in DH5α λpir and introduced into the E. coli strains HS, EcN(pSW172) or LF82(pSW172) by conjugation with S17-1 λpir as donor strain. To ensure stable replication of pSW172, all conjugation experiments were performed at 30°C.
Exconjugants in which the suicide plasmid had integrated into the chromosome by a single crossover event were recovered on LB plates containing carbenicilin and chloramphenicol. Subsequent sucrose selection was performed on sucrose plates (5 % sucrose, 8 g/l nutrient broth base, 15 g/l agar) to select for second crossover events leading to the unmarked deletion of the target gene. Deletion or incorporation of the gene of interest was confirmed by PCR. If appropriate, pSW172 was cured by cultivating the bacteria at 37°C.
The EcN ΔnarG mutant SW895 was created by introducing pSW225 into EcN(pSW172) by conjugation and subsequent sucrose selection. The napA gene in SW895(pSW172) was deleted by introduction of pSW224 and sucrose selection, thus creating SW925. To generate the ΔnarG ΔnapA ΔnarZ triple mutant (SW930), pSW237 was incorporated into the SW925(pSW172) chromosome by conjugation, sucrose selection was performed to delete the narZ gene. Similarly, the LF82 ΔnapA ΔnarG ΔnarZ triple mutant (SW963) was generated by subsequent introduction of the suicide plasmids pSW224, pSW225, and pSW237 followed in each case by sucrose selection, generating SW934 (ΔnapA) and SW595 (ΔnapA ΔnarG) in this process. To delete the moaA gene in the E. coli strains HS and EcN, pSW248 was introduced by conjugation and sucrose selection performed on exconjugants, thus creating SW1098 and SW1029, respectively. The napA deletion in the EcN ΔnarG ΔnapA ΔnarZ triple mutant (SW930) was restored with the napA wild-type allele by introducing pSW268 into SW930(pSW172) by a single crossover and subsequent sucrose selection. Bacterial numbers were determined by spreading serial ten-fold dilutions on selective LB agar plates. The competitive index was calculated by normalizing the ratio of recovered wild-type bacteria to mutant bacteria (output ratio) to the respective ratio in the inoculum (input ratio).
Nitrate reductase activity assays. Overnight cultures of E. coli strains were diluted 1:50 in fresh LB broth containing 40 mM sodium nitrate or in NCE minimal medium supplemented with 40 mM glucose and 40 mM sodium nitrate. Cultures were statically incubated for 3 h at 37°C and the relative nitrate reductase activity was measured as described previously (26) .
DSS colitis model. All experiments involving mice were approved by the
Institutional Animal Care and Use Committee at the University of California, Davis.
Female, [9] [10] [11] [12] week old C57BL/6J wild-type mice and Nos2-deficient mice (B6.129P2-Nos2tm1Lau/J) of were obtained from The Jackson Laboratory (Bar Harbor). To induce colitis, the following procedure was followed unless indicated otherwise ( Fig S1D) . The drinking water was replaced with either filter-sterilized water (mock-treatment) or with a filter-sterilized solution of 4 % (w/v) dextran sulfate sodium (DSS; relative molecular mass 36,000 -50,000; MP Biomedicals, Santa Ana) in water as indicated. For DSStreated mice, the drinking water was switched for 24 h to regular, filter-sterilized water 3 days and 1 day prior to the end of the experiment. 4 days after the start of the DSS treatment, animals were orally inoculated with either 0.1 ml of LB broth or 1 x 10 9 CFU of the indicated E. coli strains suspended in 0.1 ml LB broth. Animals were inoculated with Colonic tissue for mRNA and protein expression analysis was removed, flash frozen and stored at -80°C. Fecal material, cecal content, and colonic content was harvested in sterile PBS and the bacterial load for the E. coli strains determined by plating serial 10fold dilutions on selective agar plates. To facilitate recovery from biological samples, E. coli strains were differentially marked with the low-copy number plasmids pWSK29 and pWSK129. Both plasmids were stably replicated during the entire period and the use of two different antibiotic resistance markers did not alter the bacterial load of the relevant E. coli strains in the intestinal content (data not shown).
Measurement of nitrate concentrations in cecal mucus extracts. C57BL/6
wild-type mice were treated with 4% DSS and AG as described above. Animals were orally inoculated with 1 x 10 9 CFU of the EcN ΔnarG ΔnapA ΔnarZ triple mutant (SW930) four days after the start of the DSS treatment. Five days after inoculation, animals were euthanized. The luminal content of the cecum was removed, and the cecal mucus layer was collected and weighed. Cecal mucus was extracted with 0.2 ml ultra-pure water (Gibco), larger particles removed by centrifugation at 20,000 g for 2 min at 4°C and the filter-sterilized supernatant stored at -80°C. The nitrate concentration was determined as described previously (27) . Briefly, thawed samples were derivatized with modified Griess 
Abundance of Enterobacteriaceae.
The relative abundance of Enterobacteriaceae as part of the bacterial microbiota was analyzed as described previously (11, 31) . Briefly, the cecum was homogenized in 0. for the production of IL-10 (Cd4 Il10 mice) were inoculated with the indicated mixtures of E. coli strains (N is given in Fig. 2A) 
